Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index.
about
Arterial stiffness, vascular calcification and bone metabolism in chronic kidney diseaseAssociation of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study.The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.The association of uncarboxylated matrix Gla protein with mitral annular calcification differs by diabetes status: The Heart and Soul study.The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.Calcific uremic arteriolopathy in peritoneal dialysis populationsMarkers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland.Vitamin K-dependent proteins, warfarin, and vascular calcificationSubclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms.Vascular and valvular calcification in chronic peritoneal dialysis patients.Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients.Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein.
P2860
Q27024623-B2F1395A-B3D4-4F5B-8C49-47A30F9176FBQ33407103-E8AEB0BB-092F-41DA-845F-ABF1AF9069EEQ33769989-9E91052E-6974-4682-9A33-01EE4C116B56Q33820403-9C0E912D-1CA3-490C-A7F4-49C4575E4EBFQ34022484-B4E52362-CCF1-498E-9AF7-0050631B0401Q34241519-12BD3C41-5C21-4079-89DA-94671A118300Q34534951-D69BF785-7A8D-4FBE-B3B6-FA031BCBD802Q35073143-BB3AC331-E036-435C-ADF6-A0DD389826F4Q36538088-1F1726A4-8FC8-46B7-B4C2-95DEECEFB4CEQ36820196-85A72EE6-2589-46A6-9D92-88046CE1B1D2Q37170124-E22E56B1-1C10-44B4-9C93-9A79583A5B38Q37662635-03CD858B-B63E-4D00-8A46-4D39A6A19774Q37914009-70A6E9C4-23E5-4468-8E08-5F5605CAB439Q39369106-46103535-A73A-4AD4-A2BB-AA56C37AA64BQ43243182-0E3EE087-ABA5-4F23-8C3A-89A136C0CA82
P2860
Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Undercarboxylated matrix GLA p ...... and aortic augmentation index.
@en
Undercarboxylated matrix GLA p ...... and aortic augmentation index.
@nl
type
label
Undercarboxylated matrix GLA p ...... and aortic augmentation index.
@en
Undercarboxylated matrix GLA p ...... and aortic augmentation index.
@nl
prefLabel
Undercarboxylated matrix GLA p ...... and aortic augmentation index.
@en
Undercarboxylated matrix GLA p ...... and aortic augmentation index.
@nl
P2093
P2860
P356
P1433
P1476
Undercarboxylated matrix GLA p ...... and aortic augmentation index
@en
P2093
Jeroen P Kooman
Karel M L Leunissen
Leon J Schurgers
Marc M H Hermans
Markus Ketteler
Pieter L Rensma
Ulrich Gladziwa
Vincent Brandenburg
P2860
P304
P356
10.1159/000108629
P50
P577
2007-09-20T00:00:00Z